Recombinase Polymerase Amplification-Based Biosensors for Rapid Zoonoses Screening DOI Creative Commons
X. Feng,

Linyin Yan,

Yang Zhao

и другие.

International Journal of Nanomedicine, Год журнала: 2023, Номер Volume 18, С. 6311 - 6331

Опубликована: Ноя. 1, 2023

Abstract: Recent, outbreaks of new emergency zoonotic diseases have prompted an urgent need to develop fast, accurate, and portable screening assays for pathogen infections. Recombinase polymerase amplification (RPA) is sensitive specific can be conducted at a constant low temperature with short response time, making it especially suitable on-site powerful tool preventing or controlling the spread zoonoses. This review summarizes design principles RPA-based biosensors as well various signal output readout technologies involved in fluorescence detection, lateral flow assays, enzymatic catalytic reactions, spectroscopic techniques, electrochemical chemiluminescence, nanopore sequencing technologies, microfluidic digital RPA, clustered regularly interspaced palindromic repeats/CRISPR-associated systems. The current status prospects application zoonoses are highlighted. demonstrate advantages rapid response, easy-to-read result output, easy implementation enabling development toward greater portability, automation, miniaturization. Although there still problems such high cost unstable increasingly becoming one most important means complex samples involving environmental, water, food, animal, human diseases. Keywords: recombinase amplification, biosensor, zoonoses, nanomaterials

Язык: Английский

Advancements and applications of loop-mediated isothermal amplification technology: a comprehensive overview DOI Creative Commons
Nan Yang, Han Zhang,

Xiu Li Han

и другие.

Frontiers in Microbiology, Год журнала: 2024, Номер 15

Опубликована: Июль 17, 2024

Loop-mediated isothermal amplification (LAMP) is a novel method for nucleic acid detection known its properties, high efficiency, sensitivity, and specificity. LAMP employs 4 to 6 primers targeting 8 regions of the desired sequence, allowing at temperatures between 60 65°C production up 10

Язык: Английский

Процитировано

23

CRISPR in clinical diagnostics: bridging the gap between research and practice DOI
Zainab Lafi,

Tha’er Ata,

S. Asha

и другие.

Bioanalysis, Год журнала: 2025, Номер unknown, С. 1 - 10

Опубликована: Фев. 4, 2025

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has transformed molecular biology through its precise gene-editing capabilities. Beyond initial applications in genetic modification, emerged as a powerful tool diagnostics and biosensing. This review explores transition from genome editing to innovative detection methods, including nucleic acid identification, single nucleotide polymorphism (SNP) analysis, protein sensing. Advanced technologies such SHERLOCK DETECTR demonstrate CRISPR's potential for point-of-care diagnostics, enabling rapid highly sensitive detection. The integration of chemical modifications, CRISPR-Chip technology, enzymatic systems like Cas12a Cas13a enhances signal amplification efficiency. These advancements promise decentralized, real-time diagnostic solutions with significant implications global healthcare. Furthermore, the fusion artificial intelligence digital health platforms is paving way more accessible, cost-effective, scalable approaches, ultimately revolutionizing precision medicine.

Язык: Английский

Процитировано

3

Multiplex bacteria detection using one-pot CRISPR/Cas13a-based droplet microfluidics DOI
Yuting Shang, Gaowa Xing,

Jiaxu Lin

и другие.

Biosensors and Bioelectronics, Год журнала: 2023, Номер 243, С. 115771 - 115771

Опубликована: Окт. 18, 2023

Язык: Английский

Процитировано

42

CRISPR-Cas assisted diagnostics: A broad application biosensing approach DOI Creative Commons
Annalisa Masi, Amina Antonacci, Maria Moccia

и другие.

TrAC Trends in Analytical Chemistry, Год журнала: 2023, Номер 162, С. 117028 - 117028

Опубликована: Март 18, 2023

In addition to its remarkable genome editing capability, the CRISPR-Cas system has proven be very effective in many fields of application, including biosensing pathogenic infections, mutagenic defects, or early cancer diagnosis. Thanks their advantages terms simplicity, efficiency, and reduced time, several systems have been described for design sensitive selective analytical tools, paving way development further commercialization next-generation diagnostics. However, CRISPR-Cas-based biosensors still need research efforts improve some drawbacks, such as target amplification, low reproducibility, lack knowledge exploited element robustness. This review aims describe latest trends technologies better highlight insights point out limitations that overcome future market entry medical

Язык: Английский

Процитировано

30

CRISPR-Driven Biosensors: A New Frontier in Rapid and Accurate Disease Detection DOI

ZahraSadat Razavi,

M. Soltani, Mohammad Souri

и другие.

Critical Reviews in Analytical Chemistry, Год журнала: 2024, Номер unknown, С. 1 - 25

Опубликована: Сен. 17, 2024

This comprehensive review delves into the advancements and challenges in biosensing, with a strong emphasis on transformative potential of CRISPR technology for early rapid detection infectious diseases. It underscores versatility CRISPR/Cas systems, highlighting their ability to detect both nucleic acids non-nucleic acid targets, seamless integration isothermal amplification techniques. The provides thorough examination latest developments CRISPR-based biosensors, detailing unique properties such as high specificity programmability, which make them particularly effective detecting disease-associated acids. While focuses due its critical role diagnosing diseases, it also explores broader applications thereby acknowledging technology's potential. Additionally, identifies existing challenges, need improved signal real-world applicability, offers future perspectives aimed at overcoming these hurdles. ultimate goal is advance development highly sensitive specific biosensors that can be used widely improving human health, point-of-care settings resource-limited environments.

Язык: Английский

Процитировано

15

A general temperature-guided language model to design proteins of enhanced stability and activity DOI Creative Commons
Fan Jiang, Mingchen Li, Jiajun Dong

и другие.

Science Advances, Год журнала: 2024, Номер 10(48)

Опубликована: Ноя. 27, 2024

Designing protein mutants with both high stability and activity is a critical yet challenging task in engineering. Here, we introduce PRIME, deep learning model, which can suggest improved without any prior experimental mutagenesis data for the specified protein. Leveraging temperature-aware language modeling, PRIME demonstrated superior predictive ability compared to current state-of-the-art models on public dataset across 283 assays. Furthermore, validated PRIME’s predictions five proteins, examining impact of top 30 45 single-site mutations various properties, including thermal stability, antigen-antibody binding affinity, polymerize nonnatural nucleic acid or resilience extreme alkaline conditions. More than 30% PRIME-recommended exhibited performance their premutation counterparts all proteins desired properties. We developed an efficient effective method based rapidly obtain multisite enhanced stability. Hence, demonstrates broad applicability

Язык: Английский

Процитировано

11

Electrochemical aptasensor based on CRISPR/Cas12a-mediated and DNAzyme-assisted cascade dual-enzyme transformation strategy for zearalenone detection DOI
Yan Han, Baoshan He, Renyong Zhao

и другие.

Chemical Engineering Journal, Год журнала: 2024, Номер 493, С. 152431 - 152431

Опубликована: Май 24, 2024

Язык: Английский

Процитировано

10

Comprehensive insights into pathogenicity and emerging CRISPR-integrated biosensors for the early detection of breast cancer biomarkers DOI

Ashok Saini,

Neeraj Dilbaghi, Neelam Yadav

и другие.

Microchemical Journal, Год журнала: 2025, Номер unknown, С. 112908 - 112908

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

1

Important applications of DNA nanotechnology combined with CRISPR/Cas systems in biotechnology DOI Creative Commons
Yuqi Huang, Zhongping Chen,

Huacui Huang

и другие.

RSC Advances, Год журнала: 2025, Номер 15(8), С. 6208 - 6230

Опубликована: Янв. 1, 2025

Schematic illustration of several synthetic forms 2D and 3D DNA nanotechnology combined with CRISPR/Cas systems in biotechnology.

Язык: Английский

Процитировано

1

Sensitive and Portable Signal Readout Strategies Boost Point-of-Care CRISPR/Cas12a Biosensors DOI
Tong Li, Nan Cheng

ACS Sensors, Год журнала: 2023, Номер 8(11), С. 3988 - 4007

Опубликована: Окт. 23, 2023

Point-of-care (POC) detection is getting more and attention in many fields due to its accuracy on-site test property. The CRISPR/Cas12a system endowed with excellent sensitivity, target identification specificity, signal amplification ability biosensing because of unique trans-cleavage ability. As a result, lot research has been made develop CRISPR/Cas12a-based biosensors. In this review, we focused on readout strategies summarized recent sensitivity-improving fluorescence, colorimetric, electrochemical signaling. Then introduced novel portability-improving based lateral flow assays (LFAs), microfluidic chips, simplified instruments, one-pot design. the end, also provide our outlook for future development

Язык: Английский

Процитировано

22